drugset / Trial / NCT02578862

Total Intravenous Anesthesia in Sinus Surgery

NCT02578862 ↗

Phase 4 Completed 72 enrolled Ochsner Health System
RandomizedParallel-groupDouble-blindTreatment

Summary

Utilization of total intravenous anesthesia (TIVA) has been proposed as a method to improve visualization during endoscopic sinus surgery (ESS), largely due to its physiologic decrease in cardiac output without the peripheral smooth muscle relaxation and resultant vasodilation associated with inhaled anesthetics. This may be especially important in cases of advanced inflammatory sinus disease, when visualization may be most compromised. The goal of this study is to improve clinical practice paradigms by evaluating the use of TIVA versus inhaled anesthetic for maintenance of anesthesia in ESS for advanced paranasal sinus disease.

Timeline

Start
2015-07
Primary completion
2018-06
Completion
2018-06

Outcome

Met primary endpoint

paper Wormald scores across all reviewers demonstrated a more favorable visual field with TIVA compared to IA (3.5 [2.4-3.9] vs IA 4.1[3.0-5.8], p = 0.0089). PMID 29979837 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule — Intravenous
Comparator Sevoflurane Other / unclassified — Inhaled